Brief: Icad’S Profound Ai For Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval
14/06/2021 13:32
June 14 (Reuters) - ICAD Inc ICAD.O :
* ICAD’S PROFOUND AI FOR DIGITAL BREAST TOMOSYNTHESIS
VERSION 3.0
RECEIVES CE MARK APPROVAL
Source text for Eikon: ID:nGNX5t0FMr
Further company coverage: ICAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on icad
See all newsIcad Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: iCAD, Inc. Q1 Gross Profit USD 4.2 Million
Icad Inc Expected To Post A Loss Of 6 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP- Cognex, Equifax, Netflix
RadNet falls after $103 million all-stock acquisition to buy iCAD